These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34085693)

  • 1. Urokinase-type plasminogen activator-mediated crosstalk between N-cadherin and β-catenin promotes wound healing.
    Diaz A; Martin-Jimenez C; Xu Y; Merino P; Woo Y; Torre E; Yepes M
    J Cell Sci; 2021 Jun; 134(11):. PubMed ID: 34085693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The uPA/uPAR system in astrocytic wound healing.
    Yepes M
    Neural Regen Res; 2022 Nov; 17(11):2404-2406. PubMed ID: 35535878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase-Type Plasminogen Activator Triggers Wingless/Int1-Independent Phosphorylation of the Low-Density Lipoprotein Receptor-Related Protein-6 in Cerebral Cortical Neurons.
    Diaz A; Martin-Jimenez C; Woo Y; Merino P; Torre E; Yepes M
    J Alzheimers Dis; 2022; 89(3):877-891. PubMed ID: 35964187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.
    Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M
    J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
    Moreau M; Mourah S; Dosquet C
    Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase-type plasminogen activator (uPA) protects the tripartite synapse in the ischemic brain via ezrin-mediated formation of peripheral astrocytic processes.
    Diaz A; Merino P; Manrique LG; Cheng L; Yepes M
    J Cereb Blood Flow Metab; 2019 Nov; 39(11):2157-2171. PubMed ID: 29890880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cell.
    Lugano R; Peña E; Badimon L; Padró T
    J Thromb Haemost; 2012 Oct; 10(10):2158-67. PubMed ID: 22906080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brain.
    Merino P; Diaz A; Manrique LG; Cheng L; Yepes M
    J Biol Chem; 2018 Jun; 293(24):9234-9247. PubMed ID: 29720403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System.
    Merino P; Diaz A; Jeanneret V; Wu F; Torre E; Cheng L; Yepes M
    J Biol Chem; 2017 Feb; 292(7):2741-2753. PubMed ID: 27986809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of uPAR promotes urokinase translocation into the nucleus and epithelial to mesenchymal transition in neuroblastoma.
    Semina EV; Rubina KA; Shmakova AA; Rysenkova KD; Klimovich PS; Aleksanrushkina NA; Sysoeva VY; Karagyaur MN; Tkachuk VA
    J Cell Physiol; 2020 Sep; 235(9):6268-6286. PubMed ID: 31990070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
    Yin S; Lockett J; Meng Y; Biliran H; Blouse GE; Li X; Reddy N; Zhao Z; Lin X; Anagli J; Cher ML; Sheng S
    Cancer Res; 2006 Apr; 66(8):4173-81. PubMed ID: 16618739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase-type plasminogen activator promotes dendritic spine recovery and improves neurological outcome following ischemic stroke.
    Wu F; Catano M; Echeverry R; Torre E; Haile WB; An J; Chen C; Cheng L; Nicholson A; Tong FC; Park J; Yepes M
    J Neurosci; 2014 Oct; 34(43):14219-32. PubMed ID: 25339736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase-type plasminogen activator promotes N-cadherin-mediated synaptic recovery in the ischemic brain.
    Diaz A; Merino P; McCann P; Yepes MA; Quiceno LG; Torre E; Tomkins A; Zhang X; Hales CM; Tong FC; Yepes M
    J Cereb Blood Flow Metab; 2021 Sep; 41(9):2381-2394. PubMed ID: 33757316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.
    Nykjaer A; Kjøller L; Cohen RL; Lawrence DA; Garni-Wagner BA; Todd RF; van Zonneveld AJ; Gliemann J; Andreasen PA
    J Biol Chem; 1994 Oct; 269(41):25668-76. PubMed ID: 7929271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
    Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
    Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norrin attenuates protease-mediated death of transformed retinal ganglion cells.
    Lin S; Cheng M; Dailey W; Drenser K; Chintala S
    Mol Vis; 2009; 15():26-37. PubMed ID: 19137075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase-type Plasminogen Activator Induces Neurorepair in the Ischemic Brain.
    Merino P; Yepes M
    J Neurol Exp Neurosci; 2018; 4(2):24-29. PubMed ID: 30417161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase plasminogen activator surface receptor restricts HIV-1 replication by blocking virion release from the cell membrane.
    Pang H; Ouyang J; Yang Z; Shang H; Liang G
    Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2212991120. PubMed ID: 36638209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human urokinase-type plasminogen activator gene-modified bone marrow-derived mesenchymal stem cells attenuate liver fibrosis in rats by down-regulating the Wnt signaling pathway.
    Ma ZG; Lv XD; Zhan LL; Chen L; Zou QY; Xiang JQ; Qin JL; Zhang WW; Zeng ZJ; Jin H; Jiang HX; Lv XP
    World J Gastroenterol; 2016 Feb; 22(6):2092-103. PubMed ID: 26877613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β-mediated regulation of plasminogen activators is human telomerase reverse transcriptase dependent in cancer cells.
    Jaiswal RK; Yadava PK
    Biofactors; 2019 Sep; 45(5):803-817. PubMed ID: 31317567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.